Standard
The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan. / Spindler, Karen-Lise Garm; Vittrup, B.V.; Christensen, I.C.; Schou, J. S.; Jakobsen, A.J.; Høgdall, Estrid Vilma Solyom; Pallisgaard, Niels; Nielsen, D. N.; Johannesen, Helle Hjorth; Johansen, J. H.
In:
Annals of Oncology, Vol. 21, 2010, p. I39-I39.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Spindler, K-LG, Vittrup, BV, Christensen, IC, Schou, JS, Jakobsen, AJ, Høgdall, EVS, Pallisgaard, N, Nielsen, DN, Johannesen, HH & Johansen, JH 2010, 'The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan', Annals of Oncology, vol. 21, pp. I39-I39.
APA
Spindler, K-L. G., Vittrup, B. V., Christensen, I. C., Schou, J. S., Jakobsen, A. J., Høgdall, E. V. S., Pallisgaard, N., Nielsen, D. N., Johannesen, H. H., & Johansen, J. H. (2010). The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan. Annals of Oncology, 21, I39-I39.
Vancouver
Spindler K-LG, Vittrup BV, Christensen IC, Schou JS, Jakobsen AJ, Høgdall EVS et al. The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan. Annals of Oncology. 2010;21:I39-I39.
Author
Spindler, Karen-Lise Garm ; Vittrup, B.V. ; Christensen, I.C. ; Schou, J. S. ; Jakobsen, A.J. ; Høgdall, Estrid Vilma Solyom ; Pallisgaard, Niels ; Nielsen, D. N. ; Johannesen, Helle Hjorth ; Johansen, J. H. / The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan. In: Annals of Oncology. 2010 ; Vol. 21. pp. I39-I39.
Bibtex
@article{ff3242d25c5849989c3baf8c8161a234,
title = "The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan",
author = "Spindler, {Karen-Lise Garm} and B.V. Vittrup and I.C. Christensen and Schou, {J. S.} and A.J. Jakobsen and H{\o}gdall, {Estrid Vilma Solyom} and Niels Pallisgaard and Nielsen, {D. N.} and Johannesen, {Helle Hjorth} and Johansen, {J. H.}",
year = "2010",
language = "English",
volume = "21",
pages = "I39--I39",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
}
RIS
TY - ABST
T1 - The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan
AU - Spindler, Karen-Lise Garm
AU - Vittrup, B.V.
AU - Christensen, I.C.
AU - Schou, J. S.
AU - Jakobsen, A.J.
AU - Høgdall, Estrid Vilma Solyom
AU - Pallisgaard, Niels
AU - Nielsen, D. N.
AU - Johannesen, Helle Hjorth
AU - Johansen, J. H.
PY - 2010
Y1 - 2010
M3 - Conference abstract in journal
VL - 21
SP - I39-I39
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
ER -
